The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: A fMRI study

International Journal of Neuropsychopharmacology

Volumn 12, Issue 3, 2009, Pages 371-381

  Kempton, Matthew J ^a   Haldane, Morgan ^a   Jogia, Jigar ^a   Christodoulou, Tessa ^a   Powell, John ^a   Collier, David ^a   Williams, Steven C R ^a   Frangou, Sophia ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Amygdala; COMT; Fear; FMRI; Gender

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; OXYGEN; VALINE;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DNA POLYMORPHISM; FACIAL EXPRESSION; FEAR; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RECOGNITION; SEX DIFFERENCE; TASK PERFORMANCE; TEMPORAL CORTEX; BLOOD; BRAIN; BRAIN MAPPING; GENETIC POLYMORPHISM; GENETICS; IMAGE PROCESSING; MENSTRUAL CYCLE; METHODOLOGY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATTERN RECOGNITION; PHYSIOLOGY; REACTION TIME; VASCULARIZATION;

ADULT; BRAIN; BRAIN MAPPING; CATECHOL O-METHYLTRANSFERASE; FACIAL EXPRESSION; FEAR; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MENSTRUAL CYCLE; METHIONINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PATTERN RECOGNITION, VISUAL; POLYMORPHISM, GENETIC; REACTION TIME; SEX FACTORS; VALINE; YOUNG ADULT;

EID: 66449136003     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708009395     Document Type: Article

References (76)

1. Adolphs R (1999). The human amygdala and emotion. Neuroscientist 5, 125-137.
2. Adolphs R (2002). Recognizing emotion from facial expressions: psychological and neurological mechanisms. Behavioral and Cognitive Neuroscience Reviews 1, 21-62.
3. APA (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: American Psychiatric Association.
4. Beck AT, Clark DA (1997). An information processing model of anxiety: automatic and strategic processes. Behaviour Research and Therapy 35, 49-58.
5. Bertolino A, Blasi G, Latorre V, Rubino V, Rampino A, Sinibaldi L, Caforio G, Petruzzella V, Pizzuti A, Scarabino T, et al. (2006a). Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. Journal of Neuroscience 26, 3918-3922.
6. Bertolino A, Rubino V, Sambataro F, Blasi G, Latorre V, Fazio L, Caforio G, Petruzzella V, Kolachana B, Hariri A, et al. (2006b). Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype. Biological Psychiatry 60, 1250-1258.
7. Bilder RM, Volavka J, Lachman HM, Grace AA (2004). The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29, 1943-1961.
8. Blasi G, Mattay VS, Bertolino A, Elvevag B, Callicott JH, Das S, Kolachana BS, Egan MF, Goldberg TE, Weinberger DR (2005). Effect of catechol-O-methyltransferase val158met genotype on attentional control. Journal of Neuroscience 25, 5038-5045.
9. Boudikova B, Szumlanski C, Maidak B, Weinshilboum R (1990). Human liver catechol-O-methyltransferase pharmacogenetics. Clinical Pharmacology & Therapeutics 48, 381-389.
10. Brett M, Anton J, Valabregue R, Poline JB (2002). Region of interest analysis using an SPM toolbox [Abstract]. Presented at the 8th International Conferance on Functional Mapping of the Human Brain, 2-6 June 2002, Sendai, Japan. Available on CD-ROM in NeuroImage, vol 16, no. 2, abstract 497.
11. Calder AJ, Young AW, Rowland D, Perrett DI (1997). Computer-enhanced emotion in facial expressions. Proceedings of the Royal Society of London, Series B: Biological Sciences 264, 919-925.
12. Critchley H, Daly E, Phillips M, Brammer M, Bullmore E, Williams S, Van Amelsvoort T, Robertson D, David A, Murphy D (2000). Explicit and implicit neural mechanisms for processing of social information from facial expressions: a functional magnetic resonance imaging study. Human Brain Mapping 9, 93-105.
13. Domschke K, Freitag CM, Kuhlenbaumer G, Schirmacher A, Sand P, Nyhuis P, Jacob C, Fritze J, Franke P, Rietschel M, et al. (2004). Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. International Journal of Neuropsychopharmacology 7, 183-188. (Pubitemid 38823286)
14. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR (2006). Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Archivesof General Psychiatry 63, 1396-1406.
15. Duncan J, Seitz RJ, Kolodny J, Bor D, Herzog H, Ahmed A, Newell FN, Emslie H (2000). A neural basis for general intelligence. Science 289, 457-460.
16. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001). Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences USA 98, 6917-6922.
17. Eley TC, Tahir E, Angleitner A, Harriss K, McClay J, Plomin R, Riemann R, Spinath F, Craig I (2003). Association analysis of MAOA and COMT with neuroticism assessed by peers. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 120, 90-96.
18. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D (2003). Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatric Genetics 13, 33-41.
19. Fahndrich E, Coper H, Christ W, Helmchen H, Muller-Oerlinghausen B, Pietzcker A (1980). Erythrocyte COMT-activity in patients with affective disorders. Acta Psychiatrica Scandinavica 61, 427-437.
20. First MB, Spitzer RL, Gibbon M, Williams JBW (1997). Interview for DSM-IV Personality Disorders, (SCID-II). Washington, DC: American Psychiatric Press, Inc.
21. First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders Research Version Non-patient Edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute.
22. Floderus Y, Ross SB, Wetterberg L (1981). Erythrocyte catechol-O-methyltransferase activity in a Swedish population. Clinical Genetics 19, 389-392.
23. Floresco SB, West AR, Ash B, Moore H, Grace AA (2003). Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nature Neuroscience 6, 968-973.
24. Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig IW (2003). DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behavioural Genetics 33, 67-72.
25. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M (1998).Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences USA 95, 9991-9996.
26. Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS, Goldman D, Weinberger DR (2003). Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry 60, 889-896.
27. Grace AA (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1-24.
28. Grace AA (1993). Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. Journal of Neural Transmission (General Section) 91, 111-134.
29. Hamilton SP, Slager SL, Heiman GA, Deng Z, Haghighi F, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA (2002). Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene onchromosome 22, Biological Psychiatry 51, 591-601.
30. Hariri AR, Bookheimer SY, Mazziotta JC (2000). Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport 11, 43-48.
31. Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, Weinberger DR (2005). A susceptibility gene for affective disorders and the response of the human amygdala. Archives of General Psychiatry 62, 146-152.
32. Hong J, Shu-Leong H, Tao X, Lap-Ping Y (1998). Distribution of catechol-O-methyltransferase expression in human central nervous system. Neuroreport 9, 2861-2864.
33. Jabbi M, Kema IP, van der Pompe G, te Meerman GJ, Ormel J, den Boer JA (2007). Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response. Psychiatric Genetics 17, 183-193.
34. Jiang H, Xie T, Ramsden DB, Ho SL (2003). Human catechol-O- methyltransferase down-regulation by estradiol. Neuropharmacology 45, 1011-1018.
35. Joober R, Gauthier J, Lal S, Bloom D, Lalonde P, Rouleau G, Benkelfat C, Labelle A (2002).Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Archives of General Psychiatry 59, 662-663.
36. Karoum F, Chrapusta SJ, Brinjak R, Hitri A, Wyatt RJ (1994a). Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. British Journal of Pharmacology 113, 1391-1399.
37. Karoum F, Chrapusta SJ, Egan MF (1994b). 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. Journal of Neurochemistry 63, 972-979.
38. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB (1993). Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. Journal of Affective Disorders 29, 85-96.
39. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51, 8-19.
40. Koch K, Pauly K, Kellermann T, Seiferth NY, Reske M, Backes V, Stocker T, Shah NJ, Amunts K, Kircher T, et al. (2007). Gender differences in the cognitive control of emotion: an fMRI study. Neuropsychologia 45, 2744-2754.
41. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6, 243-250.
42. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT (2000). Automated Talairach atlas labels for functional brain mapping. Human Brain Mapping 10, 120-131.
43. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J (1995). Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34, 4202-4210.
44. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19, 1233-1239.
45. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D (2002). A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. American Journal of Psychiatry 159, 652-654.
46. Massat I, Souery D, Del-Favero J, Nothen M, Blackwood D, Muir W, Kaneva R, Serretti A, Lorenzi C, Rietschel M, et al. (2005). Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Molecular Psychiatry 10, 598-605.
47. Mathews AMB (1998). A cognitive model of selective processing in anxiety. Cognitive Therapy and Research 22, 539-560.
48. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR (2003). Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences USA 100, 6186-6191.
49. Montagne B, Kessels RPC, Frigerio E, De Haan EHF, Perrett DI (2005). Sex differences in the perception of affective facial expressions: do men really lack emotional sensitivity? Cognitive Processing 6, 136-141.
50. Moore H, West AR, Grace AA (1999). The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biological Psychiatry 46, 40-55.
51. Munro CA, McCaul ME, Wong DF, Oswald LM, Zhou Y, Brasic J, Kuwabara H, Kumar A, Alexander M, Ye W, Wand GS (2006). Sex differences in striatal dopamine release in healthy adults. Biological Psychiatry 59, 966-974.
52. Murphy FC, Nimmo-Smith I, Lawrence AD (2003). Functional neuroanatomy of emotions: a meta-analysis. Cognitive, Affective, & Behavioral Neuroscience 3, 207-233.
53. Ohara K, Nagai M, Suzuki Y, Ohara K (1998). Low activity allele of catechol-o-methyltransferase gene and Japanese unipolar depression. Neuroreport 9, 1305-1308.
54. Phan KL, Wager T, Taylor SF, Liberzon I (2002). Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 16, 331-348.
55. Phillips ML, Young AW, Senior C, Brammer M, Andrew C, Calder AJ, Bullmore ET, Perrett DI, Rowland D, Williams SC, et al. (1997). A specific neural substrate for perceiving facial expressions of disgust. Nature 389, 495-498.
56. Quinn NP, Marsden CD (1986). Menstrual-related fluctuations in Parkinson's disease. Movement Disorders 1, 85-87.
57. Revay R, Vaughan R, Grant S, Kuhar MJ (1996). Dopamine transporter immunohistochemistry in median eminence, amygdala, and other areas of the rat brain. Synapse 22, 93-99.
58. Rujescu D, Giegling I, Gietl A, Hartmann AM, Moller HJ (2003). A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biological Psychiatry 54, 34-39.
59. Schott BH, Seidenbecher CI, Fenker DB, Lauer CJ, Bunzeck N, Bernstein HG, Tischmeyer W, Gundelfinger ED, Heinze HJ, Duzel E (2006). The dopaminergic midbrain participates in human episodic memory formation: evidence from genetic imaging. Journal of Neuroscience 26, 1407-1417.
60. Smolka MN, Buhler M, Schumann G, Klein S, Hu XZ, Moayer M, Zimmer A, Wrase J, Flor H, Mann K, et al. (2007). Gene-gene effects on central processing of aversive stimuli. Molecular Psychiatry 12, 307-317.
61. Smolka MN, Schumann G, Wrase J, Grusser SM, Flor H, Mann K, Braus DF, Goldman D, Buchel C, Heinz A (2005). Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. Journal of Neuroscience 25, 836-842.
62. Smyrnis N, Avramopoulos D, Evdokimidis I, Stefanis CN, Tsekou H, Stefanis NC (2007). Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men. Biological Psychiatry 61, 845-853.
63. Stein JL, Wiedholz LM, Bassett DS, Weinberger DR, Zink CF, Mattay VS, Meyer-Lindenberg A (2007). A validated network of effective amygdala connectivity. Neuroimage 36, 736-745.
64. Stein MB, Fallin MD, Schork NJ, Gelernter J (2005). COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 30, 2092-2102.
65. Talairach J, Tourneaux P (1988). A Co-planar Stereotactic Atlas of a Human Brain. Stuttgart: Thieme.
66. Thirion B, Pinel P, Meriaux S, Roche A, Dehaene S, Poline JB (2007). Analysis of a large fMRI cohort: statistical and methodological issues for group analyses. Neuroimage 35, 105-120.
67. Tsai SJ, Yu YW, Chen TJ, Chen JY, Liou YJ, Chen MC, Hong CJ (2003). Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neuroscience Letters 338, 123-126.
68. Wager TD, Phan KL, Liberzon I, Taylor SF (2003). Valence, gender, and lateralization of functional brain anatomy in emotion: a meta-analysis of findings from neuroimaging. Neuroimage 19, 513-531.
69. Wechsler D (1981). Wechsler Adult Intelligence Scale-Revised (WAIS-R) Manual. New York: Psychological Corporation.
70. Weissman MM, Klerman GL (1977). Sex differences and the epidemiology of depression. Archives of General Psychiatry 34, 98-111.
71. Wong DF, Broussolle EP, Wand G, Villemagne V, Dannals RF, Links JM, Zacur HA, Harris J, Naidu S, Braestrup C, et al. (1988). In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences. Annals of the New York Academy of Science 515, 203-214.
72. Woo JM, Yoon KS, Choi YH, Oh KS, Lee YS, Yu BH (2004). The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. Journal of Psychiatric Research 38, 365-370.
73. Woo JM, Yoon KS, Yu BH (2002). Catechol O-methyltransferase genetic polymorphism in panic disorder. American Journal of Psychiatry 159, 1785-1787.
74. Wright CI, Fischer H, Whalen PJ, McInerney SC, Shin LM, Rauch SL (2001). Differential prefrontal cortex and amygdala habituation to repeatedly presented emotional stimuli. Neuroreport 12, 379-383.
75. Xie T, Ho SL, Ramsden D (1999). Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Molecular Pharmacology 56, 31-38.
76. Zinkstok J, Schmitz N, van Amelsvoort T, de Win M, van den Brink W, Baas F, Linszen D (2006). The COMT val158met polymorphism and brain morphometry in healthy young adults. Neuroscience Letters 405, 34-39.